spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  BPH 

 HSMN NewsFeed - 13 May 2024
Laborie Unveils Positive Study Results for Optilume(R) BPH Catheter System
Devices Urology
 HSMN NewsFeed - 20 Mar 2024
ProVerum Announces Completion of Enrollment for the ProVIDE Clinical Study for BPH and First-use of its New Flexible, Steerable Delivery System
Devices Interventional Urology
 HSMN NewsFeed - 27 Oct 2023
Laborie Medical Technologies Acquires Urotronic
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 9 Sep 2022
Nouscom Strengthens Leadership Team with the Appointments of Sven Gogov, MD, as Chief Medical Officer and Maria Arce-Tomas, PhD, as VP, Head of Regulatory Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Top-line Results from a Phase 3 Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2020
New Treatment for Urethral Strictures, Optilume(R), Receives CE Approval
Devices Urology Regulatory
 HSMN NewsFeed - 8 Jul 2020
Lumenis Launches Next-Generation MOSES(TM) 2.0 Holmium Laser Technology
Devices Urology Product Launch
 HSMN NewsFeed - 30 Aug 2019
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Aug 2019
Corinth MedTech Appoints Steven Duddy as New President and CEO
Devices Urology Personnel
 HSMN NewsFeed - 15 Mar 2019
Lumenis Announces New Clinical Breakthroughs Using Its Patent-Protected MOSES(TM) Technology
Devices Urology
 HSMN NewsFeed - 25 Jan 2019
New Four-Year Data Demonstrate Rezūm(TM) Water Vapor Therapy Offers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms
Devices Urology
 HSMN NewsFeed - 14 Jan 2019
Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 May 2018
Award-Winning Olympus Brings a "Full Circle" Urology Offering to AUA
Devices Urology Product Launch
 HSMN NewsFeed - 30 Apr 2018
Boston Scientific Closes NxThera Acquisition
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2018
Theravance Biopharma Reports Positive New Data from Multiple Studies of VIBATIV(R) (telavancin) at 2018 ECCMID(TM) Conference
Biopharmaceuticals
 HSMN NewsFeed - 21 Mar 2018
Boston Scientific Announces Agreement To Acquire NxThera
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 29 Jan 2018
Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
Biopharmaceuticals FDA Licensing
 HSMN NewsFeed - 13 Nov 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Nov 2017
Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting
Biopharmaceuticals
 HSMN NewsFeed - 20 Jul 2017
Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Biopharmaceuticals
 HSMN NewsFeed - 23 Mar 2017
Revolutionary UroLift(R) System Launches in Ireland
Devices Urology Product Launch
 HSMN NewsFeed - 15 Nov 2016
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
Devices Surgery Acquisitions
 HSMN NewsFeed - 21 Jun 2016
Theravance Biopharma Highlights Positive Top-Line Results From Pivotal Phase 3 FULFIL Study of the Closed Triple Announced by GlaxoSmithKline and Innoviva
Biopharmaceuticals
 HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Mar 2016
The European Association of Urology Upgrades UroLift(R) System Trial Data to its Highest Possible Classification - Level 1A - in its Guidelines
Devices Urology
 HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch
 HSMN NewsFeed - 2 Mar 2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 10 Nov 2014
NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate
Devices Urology Reimbursement
 HSMN NewsFeed - 17 Apr 2014
Uroplasty Names Daniel P. Merz As Vice President Of Healthcare Affairs
Devices Urology Personnel
 HSMN NewsFeed - 16 Apr 2014
Epirus and Zalicus Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions Venture Capital
 HSMN NewsFeed - 20 Mar 2014
Sophiris Adds Gerald T. Proehl to its Board of Directors
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 13 Mar 2014
NeoTract's UroLift(R) Implant Procedure for Men with Enlarged Prostate Receives Medicare and Medicaid Outpatient Billing Codes for Reimbursement
Devices Urology Reimbursement
 HSMN NewsFeed - 9 Dec 2013
American Medical Systems Receives FDA 510(k) Clearance of the RetroArc(TM) Retropubic Sling System for Treatment of Female Stress Urinary Incontinence
Devices FDA
 HSMN NewsFeed - 24 Sep 2013
First U.S. Patient Treated Following FDA Clearance of NeoTract's UroLift(R) System
Devices Urology Product Launch
 HSMN NewsFeed - 4 Sep 2013
Bard Announces Agreement to Acquire Rochester Medical, Inc.
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 23 Aug 2013
Sophiris Bio Closes $65 Million Public Offering
Biopharmaceuticals Urology Venture Capital
 HSMN NewsFeed - 9 Aug 2013
Medifocus, Inc. Announces the Initiation of Its Principal Investigational Site in Canada for Its Pivotal Phase III Clinical Trial for Breast Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 19 Jun 2013
Actavis And Kissei File Lawsuits Against Sandoz And Hetero For Infringement Of Rapaflo(R) Patent
Biopharmaceuticals Urology Generics Litigation
 HSMN NewsFeed - 4 Jun 2013
First Head-to-Head Study Shows Greenlight XPS(R) Laser Therapy Equally Safe and Effective with Faster Recovery as Commonly Used Turp for Treatment of BPH
Devices Urology
 HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Mar 2013
Merit Medical Receives CE Mark for Prostatic Artery Embolization for Embosphere(R) Microspheres
Devices Urology Regulatory
 HSMN NewsFeed - 30 Jan 2013
Urologix Names Greg Fluet as New CEO
Devices Urology Personnel
 HSMN NewsFeed - 20 Dec 2012
Robert S. Cowles, III, M.D. Joins Urodyne, Inc. and Hyperdyne, Inc., Two Subsidiaries Trimedyne Plans to Organize, as Co-Chairman and Medical Director
Devices Surgery Personnel
 HSMN NewsFeed - 19 Dec 2012
Robert S. Cowles, III, M.D. Joins Trimedyne as Its Medical Director
Devices Personnel
 HSMN NewsFeed - 30 Oct 2012
European Commission approves Cialis(R) (tadalafil) tablets for the treatment of the signs and symptoms of benign prostatic hyperplasia
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 21 Sep 2012
Cialis(R) (tadalafil) Tablets Recommended for Approval for the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia in the European Union
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 31 Aug 2012
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Biopharmaceuticals Urology
 HSMN NewsFeed - 18 Jul 2012
Endo Health Solutions Names New President of American Medical Systems
Devices Urology Personnel
 HSMN NewsFeed - 21 Jun 2012
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2012
New Study Evaluates Cialis(R) in parallel with Tamsulosin in Men with Signs and Symptoms Suggestive of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Oct 2011
Cialis(R) for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men With Both Erectile Dysfunction (ED) and Signs and Symptoms of BPH
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Apr 2011
Endo Announces Agreement to Acquire American Medical Systems for $2.9 Billion
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2011
Trimedyne Announces a Settlement and Patent License Agreement With Lumenis Ltd.
Devices Litigation Licensing
 HSMN NewsFeed - 20 Sep 2010
NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 Aug 2010
Urologix Announces Election of Christopher R. Barys as Director
Devices Urology Personnel
 HSMN NewsFeed - 16 Jul 2010
Sun Pharma Announces USFDA Approval for Generic Flomax(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 15 Jul 2010
Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.
Biopharmaceuticals Devices Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2010
AMS Receives 510(k) Clearance of Its Revolutionary MoXy(TM) Liquid Cooled Fiber for Fast, Safe Treatment of Enlarged Prostate
Devices Urology FDA
 HSMN NewsFeed - 28 Jun 2010
American Medical Systems Announces FDA Clearance for MiniArc(R) Precise Single-Incision Sling
Devices Urology FDA
 HSMN NewsFeed - 7 May 2010
Recordati Signs an Agreement With Zambon for the Co-Marketing of Silodosin in France
Biopharmaceuticals Urology Licensing
 HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
Devices Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Apr 2010
Teva Announces Launch of Generic Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Mylan Receives Approval for Generic Version of Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 3 Feb 2010
Silodosin (Urorec(R)/Silodyx) Approved by the European Commission for the Treatment of the Signs and Symptoms of BPH (Benign Prostatic Hyperplasia)
Biopharmaceuticals Urology Regulatory
 HSMN NewsFeed - 18 Dec 2009
Aeterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 9 Dec 2009
New Published Data Demonstrate Long-Term Safety, Efficacy and Tolerability of Watson's RAPAFLO(R) (silodosin) for Benign Prostatic Hyperplasia (BPH) Symptom Relief
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Dec 2009
AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Nov 2009
Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Sep 2009
TURis Plasma Vaporization Electrode from Olympus Revolutionizes the Therapy of Benign Prostatic Hyperplasia
Devices Urology
 HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 21 May 2009
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 May 2009
RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days
Biopharmaceuticals Urology
 HSMN NewsFeed - 5 May 2009
Neurocrine Announces Work Force Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2009
Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
Devices Urology
 HSMN NewsFeed - 23 Apr 2009
Urologix Announces Launch of New Catheter and Scientific Presentations at 2009 American Urological Association Annual Meeting
Devices Urology
 HSMN NewsFeed - 23 Apr 2009
Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
Devices Urology
 HSMN NewsFeed - 21 Apr 2009
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2009
Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals Urology
 HSMN NewsFeed - 24 Mar 2009
American Medical Systems Announces New General Manager of BPH Therapy Business
Devices Personnel
 HSMN NewsFeed - 6 Mar 2009
Sanofi-aventis and AEterna Zentaris Sign Agreement in the U.S.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 6 Mar 2009
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 17 Feb 2009
American Medical Systems Announces Management Change
Devices Personnel
 HSMN NewsFeed - 27 Jan 2009
Watson's GELNIQUE(TM) (oxybutynin chloride) Gel 10% Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 12 Jan 2009
Allium Group Receives CE Mark for Its Next-Generation Prostatic Stent
Devices Urology Interventional Regulatory
 HSMN NewsFeed - 22 Oct 2008
Mylan Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Oct 2008
Watson Receives US FDA Approval for RAPAFLO(TM) (silodosin) for the Treatment of Benign Prostatic Hyperplasia (BPH)
Biopharmaceuticals FDA Urology
 HSMN NewsFeed - 6 Oct 2008
Laborie Medical Technologies Announces Exclusive Distribution Agreement with T-DOC(R), LLC
Devices Distribution
 HSMN NewsFeed - 15 Jul 2008
Light Sciences Oncology Raises $40.1 Million in Series C Financing
Devices Oncology Venture Capital
 HSMN NewsFeed - 7 Jul 2008
Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 24 Jun 2008
Urologix Announces Appointment of CEO and Director
Devices Urology Personnel
 HSMN NewsFeed - 21 May 2008
Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 16 May 2008
Urologix Launches New CTC Advance Catheter at 2008 American Urological Association Annual Meeting
Devices Urology
 HSMN NewsFeed - 11 Apr 2008
AEterna Zentaris Announces Changes to its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2008
Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 10 Mar 2008
Laborie Medical Technologies Receives FDA Pre-Market Clearance for TETRA(TM)- NIRS Accessory for the US Market
Devices Urology FDA
 HSMN NewsFeed - 25 Feb 2008
Urologix Announces Leadership Changes
Devices Urology Personnel
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 18 Jan 2008
Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
Biopharmaceuticals Urology
 HSMN NewsFeed - 20 Nov 2007
Ranbaxy Launches Ran(R)-Tamsulosin Hydrochloride Capsules in Canada
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 8 Nov 2007
Ranbaxy and Astellas/Boehringer Ingelheim Enter Into an Agreement to Resolve Tamsulosin U.S. Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Nov 2007
Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Sep 2007
Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Aug 2007
Experienced Sales and Marketing Executive Rejoins Urologix
Devices Urology Personnel
 HSMN NewsFeed - 16 Aug 2007
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2007
Light Sciences Oncology Initiates Phase III Trial of Its Light Infusion Therapy (Litx(TM)) in Patients with Metastatic Colorectal Cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 26 Jun 2007
Urologix Receives CE Mark for CoolMax(TM) Microwave Catheter
Devices Urology Regulatory
 HSMN NewsFeed - 22 Jun 2007
Ranbaxy Receives Tentative Approval for Tamsulosin Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Jun 2007
Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation
Devices Acquisitions Urology
 HSMN NewsFeed - 3 Jun 2007
Constab Pharmaceutical Develops New Tool to Treat Metastatic Colorectal and Other Cancers
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 23 May 2007
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
Biopharmaceuticals Urology
 HSMN NewsFeed - 21 May 2007
Actavis Launches Finasteride 5 mg Tablets in the U.S.
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 18 May 2007
American Medical Systems Announces the Introduction of the TherMatrx TMX3000(TM) Office Thermo Therapy System
Devices Urology FDA
 HSMN NewsFeed - 18 May 2007
Quest Group International, Inc. Raises $20 Million, Acquires Extensive New Generation Oncology Portfolio and Announces Three Lead Therapeutic Product Programs
Biopharmacetuicals Oncology Licensing
 HSMN NewsFeed - 16 May 2007
Lumenis Launches 'The Power of One' for VersaPulse(R) PowerSuite(TM) at American Urology Association 2007 Annual Meeting
Devices Urology
 HSMN NewsFeed - 8 May 2007
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 May 2007
AEterna Zentaris Bolsters Management Team with Two Key Positions Named
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2007
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
Biopharmacetuicals Urology
 HSMN NewsFeed - 18 Apr 2007
Celsion Announces Boston Scientific Exercises Its Option to Purchase Prolieve(R) Assets
Devices Urology Acquisitions
 HSMN NewsFeed - 17 Apr 2007
Cook Medical Launches Full Line of Resection Electrodes Enabling Urologists to Improve Prostate Health
Devices Urology
 HSMN NewsFeed - 22 Mar 2007
Bentley Announces Approval for Tamulosin in Spain
Biopharmaceuticals Generics Regulatory
 HSMN NewsFeed - 19 Mar 2007
Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Mar 2007
Spectrum Pharmaceuticals Bolsters Ozarelix Team with Addition of In-House Urology Expert Bela S. Denes, MD, FACS
Biopharmaceuticals Urology Personnel
 HSMN NewsFeed - 14 Feb 2007
Light Sciences Oncology Initiates Phase II Trial of Litx(TM) Therapy in Patients with Glioma
Biopharmaceuticals Devices Drug Delivery Oncology
 HSMN NewsFeed - 8 Feb 2007
Celsion and AMS Settle Patent Dispute
Devices Licensing Litigation
 HSMN NewsFeed - 1 Feb 2007
Verathon Inc., Maker of BladderScan(R), Issues $10,000 Challenge to Clinicians: Develop Protocol to Study the Relationship Between Bladder Wall Mass and OAB/BPH in Men
Devices Urology
 HSMN NewsFeed - 31 Jan 2007
Study of Trimedyne's New Side Firing Laser Fiber Shows Faster Tissue Vaporization Results
Devices Urology
 HSMN NewsFeed - 30 Jan 2007
Barr Launches Generic PROSCAR(R) Tablets, 5 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 30 Jan 2007
Light Sciences Oncology Receives Special Protocol Assessment for Pivotal Phase III Trial of Litx(TM) Therapy in Metastatic Colorectal Cancer
Devices Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Jan 2007
Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
Biopharmaceuticals Urology
 HSMN NewsFeed - 16 Jan 2007
Watson Announces Positive Phase 3 Study Results on Silodosin for Treatment of Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 8 Jan 2007
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
AEterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United States and Canada
Biopharmaceuticals Urology
 HSMN NewsFeed - 3 Jan 2007
Spectrum Pharmaceuticals Announces FDA's Acceptance of Ozarelix IND and Approval of Phase 2b Protocol in BPH (Benign Prostate Hypertrophy)
Biopharmaceuticals Urology
 HSMN NewsFeed - 13 Dec 2006
Trimedyne Raises $3 Million to Finance an Expected Increase in Sales of New Laser Fiber
Devices
 HSMN NewsFeed - 27 Nov 2006
AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology
Devices Cardiology FDA
 HSMN NewsFeed - 31 Oct 2006
Ablatherm-HIFU Launches a New RPP Site in Spain; RPP Service Available in Madrid at ICUA Clinic
Devices Urology Oncology
 HSMN NewsFeed - 17 Oct 2006
AngioDynamics to Acquire Oncobionic and Its Revolutionary New Cancer Therapy
Devices Oncology Interventional Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2006
Diagnostic Ultrasound Corp., Maker of BladderScan(R) and GlideScope(R), Updates Company Name to Verathon Inc.
Devices
 HSMN NewsFeed - 3 Oct 2006
Spectrum Pharmaceuticals Announces Positive Phase 2 Data with Ozarelix in Patients with Benign Prostatic Hypertrophy
Biopharmaceuticals Urology
 HSMN NewsFeed - 3 Oct 2006
AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 29 Sep 2006
Urologix Names Elissa J. Lindsoe as Chief Financial Officer
Devices Urology Personnel
 HSMN NewsFeed - 28 Jun 2006
SurModics and AbbeyMoor Medical to Jointly Develop Drug-Device Convergence Products to Treat Diseases of the Prostate
Devices Urology
 HSMN NewsFeed - 22 May 2006
Medtronic to Pursue Pivotal Trials of Treatments for Overactive Bladder and Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 22 May 2006
Medtronic Launches PROSTIVA(TM) RF Therapy System, Proven Treatment Option for Enlarged Prostate
Devices Urology
 HSMN NewsFeed - 19 May 2006
Boston Scientific and Lumenis to Market Trimedyne's New Fiber
Devices Urology
 HSMN NewsFeed - 19 May 2006
Lumenis Announces Host of AUA 2006 Activities and Preview of New Breakthrough Laser Fiber for BPH Treatment
Devices Urology
 HSMN NewsFeed - 18 May 2006
Laserscope(R) To Launch Revolutionary New BPH Treatment Technology At Upcoming American Urological Association Meeting
Devices Urology
 HSMN NewsFeed - 16 May 2006
Nymox Reports Positive New Efficacy Data for Benign Prostatic Hyperplasia Drug
Biopharmaceuticals Urology FDA
Return to NewsFeed  

 Additional items found! 181

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 181 additional stories matching:
BPH
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.